Emergent BioSolutions asked to pause making COVID-19 vaccines

Emergent BioSolutions is not manufacturing any COVID-19 vaccines at its east Baltimore facility. In a Securities and Exchange Commission filing, the company disclosed it's retaining what it has already produced at the Bayview facility. The Food and Drug Administration began inspecting the facility on April 12, and following that inspection, the agency asked Emergent to temporarily stop manufacturing.